Global Biologics Outsourcing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 29-Sep-2021
No. of pages: 105

The Biologics Outsourcing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biologics Outsourcing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Biologics Outsourcing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Biologics Outsourcing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Antibody

- Recombinant

- Protein

- Vaccines

- Others

Market segment by Application, can be divided into

- Vaccine & Therapeutics Development

- Blood & Blood Related Products Testing

- Cellular and Gene Therapy

- Other

Market segment by players, this report covers

- Boehringer Ingelheim

- Catalent

- GenScript

- Innovent Biologics

- Syngene

- Shanghai Medicilon

- GL Biochem Corporation

- GVK Biosciences Private

- Horizon Discovery Group

- Selexis

- Lonza

- Abzena

- Adimab

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

- South America (Brazil, Argentina, Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Global Biologics Outsourcing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Biologics Outsourcing
1.2 Classification of Biologics Outsourcing by Type
1.2.1 Overview: Global Biologics Outsourcing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Biologics Outsourcing Revenue Market Share by Type in 2020
1.2.3 Antibody
1.2.4 Recombinant
1.2.5 Protein
1.2.6 Vaccines
1.2.7 Others
1.3 Global Biologics Outsourcing Market by Application
1.3.1 Overview: Global Biologics Outsourcing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Vaccine & Therapeutics Development
1.3.3 Blood & Blood Related Products Testing
1.3.4 Cellular and Gene Therapy
1.3.5 Other
1.4 Global Biologics Outsourcing Market Size & Forecast
1.5 Global Biologics Outsourcing Market Size and Forecast by Region
1.5.1 Global Biologics Outsourcing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Biologics Outsourcing Market Size by Region, (2016-2021)
1.5.3 North America Biologics Outsourcing Market Size and Prospect (2016-2026)
1.5.4 Europe Biologics Outsourcing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Biologics Outsourcing Market Size and Prospect (2016-2026)
1.5.6 South America Biologics Outsourcing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Biologics Outsourcing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biologics Outsourcing Market Drivers
1.6.2 Biologics Outsourcing Market Restraints
1.6.3 Biologics Outsourcing Trends Analysis
2 Company Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Biologics Outsourcing Product and Solutions
2.1.4 Boehringer Ingelheim Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Boehringer Ingelheim Recent Developments and Future Plans
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Biologics Outsourcing Product and Solutions
2.2.4 Catalent Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Catalent Recent Developments and Future Plans
2.3 GenScript
2.3.1 GenScript Details
2.3.2 GenScript Major Business
2.3.3 GenScript Biologics Outsourcing Product and Solutions
2.3.4 GenScript Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GenScript Recent Developments and Future Plans
2.4 Innovent Biologics
2.4.1 Innovent Biologics Details
2.4.2 Innovent Biologics Major Business
2.4.3 Innovent Biologics Biologics Outsourcing Product and Solutions
2.4.4 Innovent Biologics Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Innovent Biologics Recent Developments and Future Plans
2.5 Syngene
2.5.1 Syngene Details
2.5.2 Syngene Major Business
2.5.3 Syngene Biologics Outsourcing Product and Solutions
2.5.4 Syngene Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Syngene Recent Developments and Future Plans
2.6 Shanghai Medicilon
2.6.1 Shanghai Medicilon Details
2.6.2 Shanghai Medicilon Major Business
2.6.3 Shanghai Medicilon Biologics Outsourcing Product and Solutions
2.6.4 Shanghai Medicilon Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Shanghai Medicilon Recent Developments and Future Plans
2.7 GL Biochem Corporation
2.7.1 GL Biochem Corporation Details
2.7.2 GL Biochem Corporation Major Business
2.7.3 GL Biochem Corporation Biologics Outsourcing Product and Solutions
2.7.4 GL Biochem Corporation Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 GL Biochem Corporation Recent Developments and Future Plans
2.8 GVK Biosciences Private
2.8.1 GVK Biosciences Private Details
2.8.2 GVK Biosciences Private Major Business
2.8.3 GVK Biosciences Private Biologics Outsourcing Product and Solutions
2.8.4 GVK Biosciences Private Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GVK Biosciences Private Recent Developments and Future Plans
2.9 Horizon Discovery Group
2.9.1 Horizon Discovery Group Details
2.9.2 Horizon Discovery Group Major Business
2.9.3 Horizon Discovery Group Biologics Outsourcing Product and Solutions
2.9.4 Horizon Discovery Group Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Horizon Discovery Group Recent Developments and Future Plans
2.10 Selexis
2.10.1 Selexis Details
2.10.2 Selexis Major Business
2.10.3 Selexis Biologics Outsourcing Product and Solutions
2.10.4 Selexis Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Selexis Recent Developments and Future Plans
2.11 Lonza
2.11.1 Lonza Details
2.11.2 Lonza Major Business
2.11.3 Lonza Biologics Outsourcing Product and Solutions
2.11.4 Lonza Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Lonza Recent Developments and Future Plans
2.12 Abzena
2.12.1 Abzena Details
2.12.2 Abzena Major Business
2.12.3 Abzena Biologics Outsourcing Product and Solutions
2.12.4 Abzena Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Abzena Recent Developments and Future Plans
2.13 Adimab
2.13.1 Adimab Details
2.13.2 Adimab Major Business
2.13.3 Adimab Biologics Outsourcing Product and Solutions
2.13.4 Adimab Biologics Outsourcing Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Adimab Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biologics Outsourcing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Biologics Outsourcing Players Market Share
3.2.2 Top 10 Biologics Outsourcing Players Market Share
3.2.3 Market Competition Trend
3.3 Biologics Outsourcing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biologics Outsourcing Revenue and Market Share by Type (2016-2021)
4.2 Global Biologics Outsourcing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Biologics Outsourcing Revenue Market Share by Application (2016-2021)
5.2 Biologics Outsourcing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Biologics Outsourcing Revenue by Type (2016-2026)
6.2 North America Biologics Outsourcing Revenue by Application (2016-2026)
6.3 North America Biologics Outsourcing Market Size by Country
6.3.1 North America Biologics Outsourcing Revenue by Country (2016-2026)
6.3.2 United States Biologics Outsourcing Market Size and Forecast (2016-2026)
6.3.3 Canada Biologics Outsourcing Market Size and Forecast (2016-2026)
6.3.4 Mexico Biologics Outsourcing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Biologics Outsourcing Revenue by Type (2016-2026)
7.2 Europe Biologics Outsourcing Revenue by Application (2016-2026)
7.3 Europe Biologics Outsourcing Market Size by Country
7.3.1 Europe Biologics Outsourcing Revenue by Country (2016-2026)
7.3.2 Germany Biologics Outsourcing Market Size and Forecast (2016-2026)
7.3.3 France Biologics Outsourcing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Biologics Outsourcing Market Size and Forecast (2016-2026)
7.3.5 Russia Biologics Outsourcing Market Size and Forecast (2016-2026)
7.3.6 Italy Biologics Outsourcing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biologics Outsourcing Revenue by Type (2016-2026)
8.2 Asia-Pacific Biologics Outsourcing Revenue by Application (2016-2026)
8.3 Asia-Pacific Biologics Outsourcing Market Size by Region
8.3.1 Asia-Pacific Biologics Outsourcing Revenue by Region (2016-2026)
8.3.2 China Biologics Outsourcing Market Size and Forecast (2016-2026)
8.3.3 Japan Biologics Outsourcing Market Size and Forecast (2016-2026)
8.3.4 South Korea Biologics Outsourcing Market Size and Forecast (2016-2026)
8.3.5 India Biologics Outsourcing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Biologics Outsourcing Market Size and Forecast (2016-2026)
8.3.7 Australia Biologics Outsourcing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Biologics Outsourcing Revenue by Type (2016-2026)
9.2 South America Biologics Outsourcing Revenue by Application (2016-2026)
9.3 South America Biologics Outsourcing Market Size by Country
9.3.1 South America Biologics Outsourcing Revenue by Country (2016-2026)
9.3.2 Brazil Biologics Outsourcing Market Size and Forecast (2016-2026)
9.3.3 Argentina Biologics Outsourcing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biologics Outsourcing Revenue by Type (2016-2026)
10.2 Middle East & Africa Biologics Outsourcing Revenue by Application (2016-2026)
10.3 Middle East & Africa Biologics Outsourcing Market Size by Country
10.3.1 Middle East & Africa Biologics Outsourcing Revenue by Country (2016-2026)
10.3.2 Turkey Biologics Outsourcing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Biologics Outsourcing Market Size and Forecast (2016-2026)
10.3.4 UAE Biologics Outsourcing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Biologics Outsourcing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Biologics Outsourcing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Biologics Outsourcing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Biologics Outsourcing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Biologics Outsourcing Revenue Market Share by Region (2021-2026)
Table 6. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 7. Boehringer Ingelheim Major Business
Table 8. Boehringer Ingelheim Biologics Outsourcing Product and Solutions
Table 9. Boehringer Ingelheim Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Catalent Corporate Information, Head Office, and Major Competitors
Table 11. Catalent Major Business
Table 12. Catalent Biologics Outsourcing Product and Solutions
Table 13. Catalent Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GenScript Corporate Information, Head Office, and Major Competitors
Table 15. GenScript Major Business
Table 16. GenScript Biologics Outsourcing Product and Solutions
Table 17. GenScript Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Innovent Biologics Corporate Information, Head Office, and Major Competitors
Table 19. Innovent Biologics Major Business
Table 20. Innovent Biologics Biologics Outsourcing Product and Solutions
Table 21. Innovent Biologics Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Syngene Corporate Information, Head Office, and Major Competitors
Table 23. Syngene Major Business
Table 24. Syngene Biologics Outsourcing Product and Solutions
Table 25. Syngene Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Shanghai Medicilon Corporate Information, Head Office, and Major Competitors
Table 27. Shanghai Medicilon Major Business
Table 28. Shanghai Medicilon Biologics Outsourcing Product and Solutions
Table 29. Shanghai Medicilon Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. GL Biochem Corporation Corporate Information, Head Office, and Major Competitors
Table 31. GL Biochem Corporation Major Business
Table 32. GL Biochem Corporation Biologics Outsourcing Product and Solutions
Table 33. GL Biochem Corporation Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. GVK Biosciences Private Corporate Information, Head Office, and Major Competitors
Table 35. GVK Biosciences Private Major Business
Table 36. GVK Biosciences Private Biologics Outsourcing Product and Solutions
Table 37. GVK Biosciences Private Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Horizon Discovery Group Corporate Information, Head Office, and Major Competitors
Table 39. Horizon Discovery Group Major Business
Table 40. Horizon Discovery Group Biologics Outsourcing Product and Solutions
Table 41. Horizon Discovery Group Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Selexis Corporate Information, Head Office, and Major Competitors
Table 43. Selexis Major Business
Table 44. Selexis Biologics Outsourcing Product and Solutions
Table 45. Selexis Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Lonza Corporate Information, Head Office, and Major Competitors
Table 47. Lonza Major Business
Table 48. Lonza Biologics Outsourcing Product and Solutions
Table 49. Lonza Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Abzena Corporate Information, Head Office, and Major Competitors
Table 51. Abzena Major Business
Table 52. Abzena Biologics Outsourcing Product and Solutions
Table 53. Abzena Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Adimab Corporate Information, Head Office, and Major Competitors
Table 55. Adimab Major Business
Table 56. Adimab Biologics Outsourcing Product and Solutions
Table 57. Adimab Biologics Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Biologics Outsourcing Revenue (USD Million) by Players (2019-2021)
Table 59. Global Biologics Outsourcing Revenue Share by Players (2019-2021)
Table 60. Breakdown of Biologics Outsourcing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Biologics Outsourcing Players Head Office, Products and Services Provided
Table 62. Biologics Outsourcing Mergers & Acquisitions in the Past Five Years
Table 63. Biologics Outsourcing New Entrants and Expansion Plans
Table 64. Global Biologics Outsourcing Revenue (USD Million) by Type (2016-2021)
Table 65. Global Biologics Outsourcing Revenue Share by Type (2016-2021)
Table 66. Global Biologics Outsourcing Revenue Forecast by Type (2021-2026)
Table 67. Global Biologics Outsourcing Revenue by Application (2016-2021)
Table 68. Global Biologics Outsourcing Revenue Forecast by Application (2021-2026)
Table 69. North America Biologics Outsourcing Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Biologics Outsourcing Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Biologics Outsourcing Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Biologics Outsourcing Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Biologics Outsourcing Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Biologics Outsourcing Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Biologics Outsourcing Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Biologics Outsourcing Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Biologics Outsourcing Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Biologics Outsourcing Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Biologics Outsourcing Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Biologics Outsourcing Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Biologics Outsourcing Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Biologics Outsourcing Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Biologics Outsourcing Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Biologics Outsourcing Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Biologics Outsourcing Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Biologics Outsourcing Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Biologics Outsourcing Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Biologics Outsourcing Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Biologics Outsourcing Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Biologics Outsourcing Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Biologics Outsourcing Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Biologics Outsourcing Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Biologics Outsourcing Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Biologics Outsourcing Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Biologics Outsourcing Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Biologics Outsourcing Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Biologics Outsourcing Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Biologics Outsourcing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Biologics Outsourcing Picture
Figure 2. Global Biologics Outsourcing Revenue Market Share by Type in 2020
Figure 3. Antibody
Figure 4. Recombinant
Figure 5. Protein
Figure 6. Vaccines
Figure 7. Others
Figure 8. Biologics Outsourcing Revenue Market Share by Application in 2020
Figure 9. Vaccine & Therapeutics Development Picture
Figure 10. Blood & Blood Related Products Testing Picture
Figure 11. Cellular and Gene Therapy Picture
Figure 12. Other Picture
Figure 13. Global Biologics Outsourcing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Biologics Outsourcing Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Biologics Outsourcing Revenue Market Share by Region (2016-2026)
Figure 16. Global Biologics Outsourcing Revenue Market Share by Region in 2020
Figure 17. North America Biologics Outsourcing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Biologics Outsourcing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Biologics Outsourcing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Biologics Outsourcing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Biologics Outsourcing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Biologics Outsourcing Market Drivers
Figure 23. Biologics Outsourcing Market Restraints
Figure 24. Biologics Outsourcing Market Trends
Figure 25. Boehringer Ingelheim Recent Developments and Future Plans
Figure 26. Catalent Recent Developments and Future Plans
Figure 27. GenScript Recent Developments and Future Plans
Figure 28. Innovent Biologics Recent Developments and Future Plans
Figure 29. Syngene Recent Developments and Future Plans
Figure 30. Shanghai Medicilon Recent Developments and Future Plans
Figure 31. GL Biochem Corporation Recent Developments and Future Plans
Figure 32. GVK Biosciences Private Recent Developments and Future Plans
Figure 33. Horizon Discovery Group Recent Developments and Future Plans
Figure 34. Selexis Recent Developments and Future Plans
Figure 35. Lonza Recent Developments and Future Plans
Figure 36. Abzena Recent Developments and Future Plans
Figure 37. Adimab Recent Developments and Future Plans
Figure 38. Global Biologics Outsourcing Revenue Share by Players in 2020
Figure 39. Biologics Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Biologics Outsourcing Revenue Market Share in 2020
Figure 41. Global Top 10 Players Biologics Outsourcing Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Biologics Outsourcing Revenue Share by Type in 2020
Figure 44. Global Biologics Outsourcing Market Share Forecast by Type (2021-2026)
Figure 45. Global Biologics Outsourcing Revenue Share by Application in 2020
Figure 46. Global Biologics Outsourcing Market Share Forecast by Application (2021-2026)
Figure 47. North America Biologics Outsourcing Sales Market Share by Type (2016-2026)
Figure 48. North America Biologics Outsourcing Sales Market Share by Application (2016-2026)
Figure 49. North America Biologics Outsourcing Revenue Market Share by Country (2016-2026)
Figure 50. United States Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Biologics Outsourcing Sales Market Share by Type (2016-2026)
Figure 54. Europe Biologics Outsourcing Sales Market Share by Application (2016-2026)
Figure 55. Europe Biologics Outsourcing Revenue Market Share by Country (2016-2026)
Figure 56. Germany Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Biologics Outsourcing Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Biologics Outsourcing Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Biologics Outsourcing Revenue Market Share by Region (2016-2026)
Figure 64. China Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Biologics Outsourcing Sales Market Share by Type (2016-2026)
Figure 71. South America Biologics Outsourcing Sales Market Share by Application (2016-2026)
Figure 72. South America Biologics Outsourcing Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Biologics Outsourcing Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Biologics Outsourcing Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Biologics Outsourcing Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Biologics Outsourcing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs